Boston-based Perceptive Informatics, an eClinical solutions provider and a subsidiary of CRO Parexel International, found in a global survey that over half (54%) of respondents review medical imaging-related study metrics on a regular basis. Of those respondents, 81% use medical imaging metrics as actionable data to inform progress toward the achievement of study milestones. Key performance indicators used by the respondents include the status of site qualification for imaging-based clinical trials, as well as progress of medical image submissions, query responses and radiology reviews.
The survey polled biopharmaceutical industry professionals across a range of outsourcing, clinical operations and technical functions about the value of accessing medical imaging metrics to provide greater visibility into clinical trials and to achieve major study milestones, during Perceptive’s webinar entitled "Medical Imaging Web Reporting: Helping Sponsors Simplify Central Imaging Study Management through Metrics."
"Industry-standard performance metrics for imaging core labs have become an important element of effective study management,” said Kenneth G. Faulkner, Ph.D., vice president, medical imaging at Perceptive Informatics. “Centralized access to medical imaging metrics for multiple trials and cross-study program monitoring is especially critical for comprehensive analysis."
The medical imaging reporting solution from Perceptive Informatics is designed to present medical imaging data for improved analysis and decision-making, and is aligned with industry-standard metrics for imaging core labs, as defined by the Metrics Champion Consortium (MCC), allowing trial sponsors to track progress against MCC criteria.